Teva Pharmaceutical Industries (TEVJF) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Teva Pharmaceutical Industries (TEVJF) over the last 17 years, with Q4 2025 value amounting to $3.6 billion.
- Teva Pharmaceutical Industries' Cash & Current Investments rose 775.76% to $3.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.6 billion, marking a year-over-year increase of 775.76%. This contributed to the annual value of $3.6 billion for FY2025, which is 775.76% up from last year.
- Latest data reveals that Teva Pharmaceutical Industries reported Cash & Current Investments of $3.6 billion as of Q4 2025, which was up 775.76% from $2.2 billion recorded in Q3 2025.
- Teva Pharmaceutical Industries' Cash & Current Investments' 5-year high stood at $3.6 billion during Q4 2025, with a 5-year trough of $1.7 billion in Q1 2025.
- In the last 5 years, Teva Pharmaceutical Industries' Cash & Current Investments had a median value of $2.2 billion in 2022 and averaged $2.5 billion.
- In the last 5 years, Teva Pharmaceutical Industries' Cash & Current Investments skyrocketed by 4757.67% in 2024 and then crashed by 4326.31% in 2025.
- Teva Pharmaceutical Industries' Cash & Current Investments (Quarter) stood at $2.2 billion in 2021, then increased by 29.38% to $2.8 billion in 2022, then increased by 15.17% to $3.2 billion in 2023, then increased by 2.29% to $3.3 billion in 2024, then rose by 7.76% to $3.6 billion in 2025.
- Its Cash & Current Investments was $3.6 billion in Q4 2025, compared to $2.2 billion in Q3 2025 and $2.2 billion in Q2 2025.